Ilaria Marcon

657 total citations
17 papers, 366 citations indexed

About

Ilaria Marcon is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ilaria Marcon has authored 17 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ilaria Marcon's work include Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). Ilaria Marcon is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). Ilaria Marcon collaborates with scholars based in Italy, Malaysia and Lebanon. Ilaria Marcon's co-authors include Michela Casanova, Andrea Ferrari, Paola Collini, Monica Terenziani, Mario Santinami, Elisabetta Pennacchioli, Cesare Bartoli, Aldo Bono, Marco Guzzo and G. Scaramellini and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer.

In The Last Decade

Ilaria Marcon

16 papers receiving 357 citations

Peers

Ilaria Marcon

ONCOL

PRM

SURGE

PFM

DERMA

Pietro Del Medico Italy

Edi Viale Italy

Diane M. Maia United States

Aseem Lal United States

Afef Khanfir Tunisia

Olga L. Bohn United States

Shigeo Nakamura Japan

Paola Poletti Italy

Emanuele Dainese Italy

Jula Veerapong United States

Pietro Del Medico Italy

Ilaria Marcon

207 ×0.7

ONCOL

86 ×0.8

PRM

112 ×1.2

SURGE

40 ×0.5

PFM

46 ×0.9

DERMA

Citations per year, relative to Ilaria Marcon Ilaria Marcon (= 1×) peers Pietro Del Medico

Countries citing papers authored by Ilaria Marcon

Since Specialization

Citations

This map shows the geographic impact of Ilaria Marcon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilaria Marcon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilaria Marcon more than expected).

Fields of papers citing papers by Ilaria Marcon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilaria Marcon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilaria Marcon. The network helps show where Ilaria Marcon may publish in the future.

Co-authorship network of co-authors of Ilaria Marcon

This figure shows the co-authorship network connecting the top 25 collaborators of Ilaria Marcon. A scholar is included among the top collaborators of Ilaria Marcon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilaria Marcon. Ilaria Marcon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Marcon, Ilaria, et al.. (2023). Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy. Advances in Therapy. 40(9). 3875–3895. 2 indexed citations

Vecchio, Michele Del, Vanna Chiarion‐Sileni, Pietro Quaglino, et al.. (2023). The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study. Cancers. 15(7). 1980–1980.

Aglietta, Massimo, Vanna Chiarion‐Sileni, Paolo Fava, et al.. (2023). Outcomes in patients with BRAF^V600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib. Tumori Journal. 109(6). 537–545. 1 indexed citations

Aglietta, Massimo, Vanna Chiarion‐Sileni, Paolo Fava, et al.. (2021). Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy). Targeted Oncology. 16(6). 789–799. 5 indexed citations

Gallo, Daniela, Ilaria Marcon, Elisabetta Armiraglio, et al.. (2020). When primary hyperparathyroidism comes as good news. Endocrinology Diabetes and Metabolism Case Reports. 2020. 4 indexed citations

Marcon, Ilaria, et al.. (2016). Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy. Digestive and Liver Disease. 48(8). 974–974. 9 indexed citations

Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male breast cancer: Clinical features and multimodal treatment in a retrospective survey analysis at Italian centers. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 3 indexed citations

Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male Breast Cancer: Clinical Features and Multimodal Treatment in a Retrospective Survey Analysis at Italian Centers. Tumori Journal. 99(5). 596–600. 4 indexed citations

Santoro, Armando, Alessandro Comandone, Umberto Basso, et al.. (2012). Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy. Annals of Oncology. 24(4). 1093–1098. 48 indexed citations

10.

Carnaghi, Carlo, Armando Santoro, Lorenza Rimassa, et al.. (2007). The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study. Investigational New Drugs. 25(5). 479–485. 12 indexed citations

11.

Guzzo, Marco, Andrea Ferrari, Ilaria Marcon, et al.. (2006). Salivary gland neoplasms in children: The experience of the Istituto Nazionale Tumori of Milan. Pediatric Blood & Cancer. 47(6). 806–810. 72 indexed citations

12.

Ferrari, Andrea, Aldo Bono, Paola Collini, et al.. (2005). ¿El melanoma se comporta mejor en los niños pequeños que en los adultos? Un estudio retrospectivo de 33 casos de melanoma infantil en una única institución. PEDIATRICS. 59(3). 147–152. 1 indexed citations

13.

Garassino, I., Carlo Carnaghi, Lorenza Rimassa, et al.. (2005). Definitive results of hybrid chemotherapy with intravenous (iv) oxaliplatin (OXA) and folinic acid (FA), and intra-hepatic infusion (HAI) of 5-fluorouracil (5-FU) in patients with colorectal liver metastases. Journal of Clinical Oncology. 23(16_suppl). 3670–3670. 3 indexed citations

14.

Ferrari, Andrea, Aldo Bono, Paola Collini, et al.. (2005). Does Melanoma Behave Differently in Younger Children Than in Adults? A Retrospective Study of 33 Cases of Childhood Melanoma From a Single Institution. PEDIATRICS. 115(3). 649–654. 139 indexed citations

15.

Marcon, Ilaria, Paola Collini, Michela Casanova, Cristina Meazza, & Andrea Ferrari. (2004). CUTANEOUS ANGIOSARCOMA IN A PATIENT WITH XERODERMA PIGMENTOSUM. Pediatric Hematology and Oncology. 21(1). 23–26. 10 indexed citations

16.

Marcon, Ilaria, Paola Collini, Michela Casanova, Cristina Meazza, & Andrea Ferrari. (2004). Cutaneous Angiosarcoma in a Patient with Xeroderma Pigmentosum. Pediatric Hematology and Oncology. 21(1). 23–26. 6 indexed citations

17.

Casanova, Michela, Andrea Ferrari, Filippo Spreafico, et al.. (2002). Vinorelbine in previously treated advanced childhood sarcomas. Cancer. 94(12). 3263–3268. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact